Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1081 | 1036 | 1203 | 1272 | 1542 | 2022 |
Fund Return | 8.11% | 3.61% | 20.27% | 8.34% | 9.05% | 7.3% |
Place in category | 219 | 212 | 143 | 215 | 293 | 189 |
% in Category | 44 | 41 | 24 | 37 | 60 | 53 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AGF Global Select Series F CAD | 4.58B | 15.44 | 8.60 | 15.86 | ||
AGF American Growth Class Series T | 3.26B | 16.06 | 11.50 | 14.54 | ||
AGF American Growth Class CAD | 3.26B | 16.04 | 11.42 | 14.45 | ||
AGF Global Dividend Fund Series Q | 2.31B | 10.11 | 10.46 | 10.23 | ||
AGF Global Dividend Fund Series T | 2.31B | 8.98 | 7.93 | 7.71 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Canadian Growth Comp Sr A | 11.14B | 20.28 | 9.95 | 13.25 | ||
Fidelity Canadian Growth Comp Sr F | 11.14B | 20.98 | 11.47 | 14.80 | ||
Fidelity Canadian Growth Comp Sr B | 11.14B | 20.40 | 10.20 | 13.48 | ||
Fidelity Canadian Large Cap Sr F | 7.51B | 6.05 | 11.61 | 9.51 | ||
Fidelity Canadian Large Cap Sr F5 | 7.51B | 6.05 | 11.62 | 9.51 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Toronto Dominion Bank | CA8911605092 | 4.13 | 74.53 | -0.04% | |
UnitedHealth | US91324P1021 | 3.83 | 497.12 | -0.04% | |
Canadian Natural | CA1363851017 | 3.69 | 46.62 | -0.53% | |
Microsoft | US5949181045 | 3.62 | 442.57 | +0.22% | |
Apple | US0378331005 | 3.32 | 212.49 | -0.82% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Buy | Buy |
Technical Indicators | Sell | Strong Buy | Strong Buy |
Summary | Sell | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review